Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1

Lancet

Volumn 357, Issue 9267, 2001, Pages 1519-1523

  Harries, Anthony D ^a   Hargreaves, Nicola J ^a,b   Kemp, Julia ^a,b   Jindani, Amina ^c   Enarson, Donald A ^c   Maher, Dermot ^d   Salaniponi, Felix M ^a  

^a National Tuberculosis Control Programme Malawi   (Malawi)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; COTRIMOXAZOLE; FANSIDAR; MULTIVITAMIN; PYRIMETHAMINE; QUINOLONE DERIVATIVE; RIFAMPICIN; TRACE ELEMENT;

AFRICA; ANEMIA; BACTEREMIA; DEATH; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE CONTROL; HERXHEIMER REACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; LUNG TUBERCULOSIS; MALARIA; MORTALITY; OPPORTUNISTIC INFECTION; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 0035849302     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04639-0     Document Type: Note

References (29)

1. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. for the WHO global surveillance and monitoring project. Global Burden of Tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA. 282:1999;677-686.
2. World Health Organization. Global Tuberculosis Control: WHO Report 2000. Geneva: WHO, 2000 (WHO/CDS/TB/2000.275).
3. Raviglione M.C., Harries A.D., Msiska R., Wilkinson D., Nunn P. Tuberculosis and HIV: current status in Africa. AIDS. 11:(suppl B):1997;S115-S123.
4. Harries A.D., Nyangulu D.S., Kang'ombe C., et al. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba hospital, Malawi. Trans R Soc Trop Med Hyg. 92:1998;343-347.
5. Steen T.W., Mazonde G.N. Pulmonary tuberculosis in Kweneng District, Botswana: delays in diagnosis in 212 smear-positive patients. Int J Tuberc Lung Dis. 2:1998;627-634.
6. Lawn S.D., Afful B., Acheampong J.W. Pulmonary tuberculosis: diagnostic delay in Ghanaian adults. Int J Tuberc Lung Dis. 2:1998;635-640.
7. Salaniponi F.M.L., Harries A.D., Banda H.T., et al. Care seeking behaviour and diagnostic processes in patients with smear-positive pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis. 4:2000;327-332.
8. Salaniponi F.M.L., Gausi F., Kwanjana J.H., Harries A.D. Time between sputum examination and treatment in patients with smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis. 4:2000;581-583.
9. Lawn S.D., Shattock R.J., Griffin G.E. Delays in the diagnosisof tuberculosis: a great new cost. Int J Tuberc Lung Dis. 1:1997;485-486.
10. Whalen C.C., Nsubuga P., Okwera A., et al. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS. 14:2000;1219-1228.
11. Nunn P., Brindle R., Carpenter L., et al. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Am Rev Respir Dis. 146:1992;849-854.
12. Okwera A., Whalen C., Byekwaso F., et al. Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. Lancet. 344:1994;1323-1328.
13. Elliott A.M., Halwindii B., Hayes R.J., et al. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Trans R Soc Trop Med Hyg. 89:1995;78-82.
14. WHO. Treatment of tuberculosis: guidelines for national programmes, 2nd edn. Geneva: WHO, 1997 (WHO/TB/97.220).
15. Ministry of Health. Manual of the National Tuberculosis Control Programme in Malawi, 4th edn. Malawi: Ministry of Health & Population, 1991.
16. Maher D., van Gorkom J.L.C., Gondrie P.C.F.M., Raviglione M. Community contribution to tuberculosis care in countries with high tuberculosis prevalence: past, present and future. Int J Tuberc Lung Dis. 3:1999;762-768.
17. Wiktor S.Z., Sassan-Morroko M., Grant A.D., et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1 infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet. 353:1999;1469-1475.
18. Harries A.D., Kamenya A., Subramanyam V.R., et al. Screening pulmonary tuberculosis suspects in Malawi: testing different strategies. Trans R Soc Trop Med Hyg. 91:1997;416-419.
19. Foulds J., O'Brien R. New tools for the diagnosis of tuberculosis: the perspective of developing countries. Int J Tuberc Lung Dis. 2:1998;778-783.
20. Peloquin C.A., MacPhee A.A., Berning S.E. Malabsorption of antimycobacterial medications. N Engl J Med. 329:1993;1122.
21. Enarson DA, Rieder HL, Arnadottir T, Trebucq A. Tuberculosis guide for low income countries, 4th edn. Paris: International Union against Tuberculosis and Lung Disease, 1996.
22. Ellis M.E., Webb A.K. Cause of death in patients admitted to hospital for pulmonary tuberculosis. Lancet. 1:1983;665-667.
23. Alzeer A.H., FitzGerald J.M. Corticosteroids and tuberculosis: risks and use as adjunct therapy. Tuber Lung Dis. 74:1993;6-11.
24. Hakim J.G., Ternouth I., Mushangi E., et al. Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculosis pericarditis. Heart. 80:2000;183-188.
25. UNAIDS. Provisional WHO/UNAIDS secretariat recommendations on the use of cotrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. Geneva: UNAIDS, 2000.
26. Baum M.K., Shor-Posner G., Lu Y., et al. Micronutrients and HIV-1 disease progression. AIDS. 9:1995;1051-1056.
27. Tang A.M., Graham N.M.H., Semba R.D., Saah A.J. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS. 11:1997;613-620.
28. Pozniak A.L., Miller R., Ormerod L.P. The treatment of tuberculosis in HIV-infected persons. AIDS. 13:1999;435-445.
29. Harries A.D., Nyirenda T.E., Banerjee A., Boeree M.J., Salaniponi F.M.L. Tuberculosis in health care workers in Malawi. Trans R Soc Trop Med Hyg. 93:1999;32-35.